Skip to main content
Clinical Trials/NCT06732622
NCT06732622RecruitingNot Applicable

Laser Acupuncture for Idiopathic Bell's Palsy: a Randomized Controlled Trial

Beijing Tongren Hospital1 site in 1 country360 target enrollmentStarted: December 1, 2024Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
360
Locations
1
Primary Endpoint
House Brackmann Grading System (HB)

Study Overview

Brief Summary

Bell's palsy is characterized by acute, unilateral onset that compromises function and esthetics, exerting a considerable impact on the social, professional, and psychological aspects of the lives of affected individuals. The objective of this study was to determine whether laser acupuncture therapy could relieve symptoms in patients with Bell's palsy.

Detailed Description

This study was randomized controlled trial including 360 patients that undergoing Bell's palsy. All the patients received oral Prednisolone. Patients were assigned to the laser acupuncture (LA) group, Sham LA group and control group, with 120 patients in each group. LA group and Sham LA group were received 4 weeks of Laser treatment (3 times per week).

Clinical outcome measure comprised the House-Brackmann grading system, Sunnybrook facial grading scale (SBFG), Facial Disability Index (FDI) and Facial Clinimetric Evaluation Scale (FaCE Scale) All the measurements were collected at the baseline, weeks 2, 4, 6, 8, 12 and 24.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients diagnosed with idiopathic Bell's Palsy 2.Patients were eligible if they were graded at House-Brackmann grade (HB) 3 or higher.

Exclusion Criteria

  • Serious mental illness or social problems, and neurological disorders, and systemic diseases, such as malignant tumors, and other serious consumptive diseases.
  • Planning for pregnancy, those in pregnancy, or those who were lactating. 3.Bell's Palsy patients who have a disease course of more than 8 weeks.

Arms & Interventions

Laser acupuncture Group

Experimental

Intervention: Laser acupuncture (Device)

Laser acupuncture Group

Experimental

Intervention: Steroids (Drug)

Sham laser acupuncture Group

Sham Comparator

Intervention: Steroids (Drug)

Sham laser acupuncture Group

Sham Comparator

Intervention: Sham laser acupuncture (Device)

Control group

Other

Intervention: Steroids (Drug)

Outcomes

Primary Outcomes

House Brackmann Grading System (HB)

Time Frame: Baseline, weeks 2, 4, 6, 8, 12 and 24

The HB is a physician-rated system based on criteria of resting appearance, facial movements, and synkinesis that categorizes facial function from I (normal) to VI (total paralysis), with options of "Normal", "Mild dysfunction", "Moderate dysfunction", "Moderately severe dysfunction", "Severe dysfunction" or "Total paralysis". The prognoses of grade 3 or higher were abnormal.

Secondary Outcomes

  • Sunnybrook Facial Grading Scale (SB Grading)(Baseline, weeks 2, 4, 6, 8, 12 and 24)
  • Facial Disability Index (FDI)(Baseline, weeks 2, 4, 6, 8, 12 and 24)
  • Facial Clinimetric Evaluation Scale (FaCE Scale)(Baseline, weeks 2, 4, 6, 8, 12 and 24)

Investigators

Sponsor
Beijing Tongren Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials